Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 2, 2023

Rhea-AI Summary

Acadia Pharmaceuticals to report Q3 financial results and host conference call

Positive

• Acadia Pharmaceuticals will report its third quarter financial results on November 2, 2023.
• The company's management team will host a conference call and webcast to discuss financial results and operations.
• The conference call will be available on Acadia's website and will be archived until December 4, 2023.

Negative

• None.

Company to host conference call and webcast on Thursday, November 2, 2023, at 4:30 p.m. Eastern Time

SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report third quarter financial results on Thursday, November 2, 2023, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on November 2, 2023, at 4:30 p.m. Eastern Time to discuss financial results and operations.

The conference call will be available on Acadia’s website, www.acadia.com under the investors section and will be archived there until December 4, 2023. The conference call may also be accessed by registering for the call here. Once registered, participants will receive an email with the dial-in number and unique PIN number to use for accessing the call.

About Acadia Pharmaceuticals

Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Prader-Willi syndrome, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at www.acadia.com and follow us on LinkedIn and Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231019859462/en/

Media Contact:

Acadia Pharmaceuticals Inc.

Deb Kazenelson

(818) 395-3043

media@acadia-pharm.com

Investor Contact:

Acadia Pharmaceuticals Inc.

Al Kildani

(858) 261-2872

ir@acadia-pharm.com

Acadia Pharmaceuticals Inc.

Jessica Tieszen

(858) 261-2950

ir@acadia-pharm.com

Source: Acadia Pharmaceuticals Inc.

FAQ

When will Acadia Pharmaceuticals report its third quarter financial results?

Acadia Pharmaceuticals will report its third quarter financial results on November 2, 2023.

What will be discussed during the conference call and webcast?

The conference call and webcast will discuss Acadia Pharmaceuticals' financial results and operations.

Where can I access the conference call?

The conference call can be accessed on Acadia Pharmaceuticals' website.

How long will the conference call be available for?

The conference call will be archived on Acadia Pharmaceuticals' website until December 4, 2023.